Advertisement

Biological Mechanisms and Toxicological Consequences of the Methylation of Arsenic

  • M. Styblo
  • M. Delnomdedieu
  • D. J. Thomas
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 115)

Abstract

Since ancient times, arsenic (As) has been recognized as an agent with potent biological effects (FRost 1967). Both Hippocrates and Galen described the medicinal use of As-containing sulfides and oxides (BUchanan 1962). In the era before penicillin, the antibiotic potency of organic As (organoAs) compounds made them an important part of the pharmaceutical armamentarium (GOodman and GIlman 1941). The potent toxicity of As results in its continued use as a component of insecticides, herbicides, and rodenticides and as a wood preservative. As has long been used in glass-making, and As-containing semiconductors will likely play an increasingly large role in electronics manufacture.

Keywords

Urinary Excretion Inorganic Arsenic Arsenic Trioxide Dimethylarsinic Acid Marmoset Monkey 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anundi I, Hogberg J, Vahter M (1982) GSH release in bile as influenced by arsenite. FEBS Lett 145:285–288PubMedGoogle Scholar
  2. Bertolero F, Marafante E, Edel Rade J, Pietra R, Sabbioni E (1981) Biotransformation and intracellular binding of arsenic in tissue of rabbits after intraperitoneal administration of 74As labelled arsenite. Toxicology 20:35–44PubMedGoogle Scholar
  3. Braman RS, Foreback CC (1973) Methylated forms of arsenic in the environment. Science 182:1247–1249PubMedGoogle Scholar
  4. Buchanan WD (1962) Toxicity of arsenic compounds. Elsevier, AmsterdamGoogle Scholar
  5. Buchet JP, Lauwerys R (1985) Study of inorganic arsenic methylation by rat in vitro:relevance for the interpretation of observations in man. Arch Toxicol 57:125–129PubMedGoogle Scholar
  6. Buchet JP, Lauwerys R (1987) Study of factors influencing the in vivo methylation of inorganic arsenic in rats. Toxicol Appl Pharmacol 91:65–74PubMedGoogle Scholar
  7. Buchet JP, Lauwerys R (1988) Role of thiols in the in vitro methylation of inorganic arsenic by rat liver cytosol. Biochem Pharmacol 37:3149–3153PubMedGoogle Scholar
  8. Buchet JP, Lauwerys R, Roels H (1981a) Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite. Int Arch Occup Environ Health 48:111–118Google Scholar
  9. Buchet JP, Lauwerys R, Roels H (1981b) Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int Arch Occup Environ Health 48:71–79Google Scholar
  10. Buchet JP, Geubel A, Pauwels S, Mahieu P, Lauwerys R (1984) The influence of liver disease on the methylation of arsenite in humans. Arch Toxicol 55:151–154PubMedGoogle Scholar
  11. Cannon JR, Edmonds JS, Francesconi KA, Raston CL, Saunders JB, Skelton BW, White AH (1981) Isolation, crystal structure and synthesis of arsenobetaine a constituent of the western rock lobster Panulirus cygnus, the dusky shark, Carcharhinus obscurus and some samples of human urine. Aust J Chem 34:787–798Google Scholar
  12. Cebrián ME, Del Razo LM, García-Vargas G (1993) Indicators of susceptibility and damage in arsenic exposed populations. In: Book of abstracts, International Conference on Arsenic Exposure. 28–30 July 1993, New Orleans, LA, p 12Google Scholar
  13. Challenger F (1945) Biological methylation. Chem Revs 36:315–361Google Scholar
  14. Challenger F (1951) Biological methylation. Adv Enzymol 12:429–491Google Scholar
  15. Chen CJ, Chuang YC, Lin TM, Wu HY (1985) Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan:high arsenic artesian well water and cancers. Cancer Res 45:5895–5899PubMedGoogle Scholar
  16. Chen CJ, Wu MM, Lee SS, Wang JD, Cheng SH, Wu HY (1988) Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 8:452–460PubMedGoogle Scholar
  17. Coulson EJ, Remington RE, Lynch KM (1935) Metabolism in the rat of the naturally occurring arsenic of shrimp as compared with arsenic trioxide. J Nutr 10:255–270Google Scholar
  18. Cox DP, Alexander M (1973) Production of trimethylarsine gas from various arsenic compounds by three sewage fungi. Bull Environ Contam Toxicol 9:84–88PubMedGoogle Scholar
  19. Crecelius EA (1977) Changes in the chemical speciation of arsenic following ingestion by man. Environ Health Perspect 19:147–150PubMedGoogle Scholar
  20. Dabeka RW, McKenzie AD, Lacroix GMA, Cleroux C, Bowe S, Graham RA, Conacher HBS, Verdier P (1993) Survey of arsenic in total diet food composites and estimation of the dietary intake of arsenic by Canadian adults and children. J AOAC Int 76:14–25PubMedGoogle Scholar
  21. Delnomdedieu M, Basti MM, Otvos JO, Thomas DJ (1993) Transfer of arsenite from glutathione to dithiol:a model of interaction. Chem Res Toxicol 6:598–602PubMedGoogle Scholar
  22. Delnomdedieu M, Basti MM, Otvos JO, Thomas DJ (1994) Reduction of arsenate and dimethylarsinate by glutathione: a magnetic resonance study. Chem Biol Interact (in press)Google Scholar
  23. Doerfler W (1983) DNA methylation and differentiation. Annu Rev Biochem 52:93–124PubMedGoogle Scholar
  24. Doi R (1991) Individual difference of methylmercury metabolism in animals and its significance in methylmercury toxicity. In:Imura N, Clarkson TW (eds) Advances in mercury toxicology. Plenum, New York, p 77Google Scholar
  25. Edmonds JS, Francesconi KA, Cannon JR, Raston CL, Skelton BW, White AH (1977) Isolation, crystal structure and synthesis of arsenobetaine, the arsenical constituent of the western rock lobster Panulirus longipes cygnus George. Tetrahedron Lett 18:1543–1546Google Scholar
  26. Fearon EH, Vogelstein B (1990) A genetic model for colorectal carcinogenesis. Cell 61:757–767Google Scholar
  27. Foa V, Colombi A, Maroni M, Buratti M, Calzaferri G (1984) The speciation of chemical forms of arsenic in the biological monitoring of exposure to inorganic arsenic. Sci Total Environ 34:241–259PubMedGoogle Scholar
  28. Frost DV (1967) Arsenicals in biology. Retrospect and prospect. Fed Proc 26:194–208PubMedGoogle Scholar
  29. Fuentes N, Zambrano F, Rosenmann M (1981) Arsenic contamination:metabolic effects and localization in rats. Comp Biochem Physiol 70C:269–272Google Scholar
  30. Gadd GM (1993) Microbial formation and transformation of organometallic and organometalloid compounds. FEMS Microbiol Rev 11:297–316Google Scholar
  31. Georis B, Cardenas A, Buchet JP, Lauwerys R (1990) Inorganic arsenic methylation by rat tissue slices. Toxicology 63:73–84PubMedGoogle Scholar
  32. Geubel AP, Mairlot MC, Buchet JP, Dive C, Lauwerys R (1988) Abnormal methylation capacity in human liver cirrhosis. Int J Clin Pharmacol Res VIII:117–122Google Scholar
  33. Goodman LS, Gilman A (1941) Drugs used in the chemotherapy of syphilis. I. The pharmacology and clinical toxicology of the anti syphilitic arsenicals — the arsphenamines, mapharsen and tryparasamide. In: The pharmacological basis of therapeutics, 2nd edn. Macmillan, New York, p 946Google Scholar
  34. Gyurasics A, Varga F, Gregus Z (1991a) Effects of arsenicals on biliary excretion of endogenous glutathione and xenobiotics with glutathione-dependent hepatobiliary transport. Biochem Pharmacol 41:937–944Google Scholar
  35. Gyurasics A, Varga F, Gregus Z (1991b) Glutathione-dependent biliary excretion of arsenic. Biochem Pharmacol 42:465–468Google Scholar
  36. Harvey SC (1970) Arsenic. In:Goodman LS, Gilman A (eds) The pharmacological basis of therapeutics, 4th edn. Macmillan, New York, p 958Google Scholar
  37. Hirata M, Hisanaga A, Tanaka A, Ishinishi N (1988) Glutathione and methylation of inorganic arsenic in hamsters. Appl Organomet Chem 2:315–320Google Scholar
  38. Hirata M, Mohri T, Hisanaga A, Ishinishi N (1989) Conversion of arsenite and arsenate to methylarsenic and dimethylarsenic compounds by homogenates prepared from livers and kidneys of rats and mice. Appl Organomet Chem 3:335–341Google Scholar
  39. Hirata M, Tanaka A, Hisanaga A, Ishinishi N (1990) Effects of glutathione depletion on the acute nephrotoxic potential of arsenite and on arsenic metabolism in hamsters. Toxicol Appl Pharmacol 106:469–481PubMedGoogle Scholar
  40. Hoffman JL (1980) The rate of transmethylation in mouse liver as measured by trapping S-adenosylhomocysteine. Arch Biochem Biophys 205:132–135PubMedGoogle Scholar
  41. Hopenhayn-Rich C, Smith AH, Goeden HM (1993) Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ Res 60:161–177PubMedGoogle Scholar
  42. Huang H, Huang CF, Wu DR, Jinn CM, Jan KY (1993) Glutathione as a cellular defense against arsenite toxicity in cultured Chinese hamster ovary cells. Toxicology 79:195–204PubMedGoogle Scholar
  43. Hughes MF, Menache M, Thompson DJ (1994) Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fund Appl Toxicol 22:80–89Google Scholar
  44. Hunter FT, Kip AF, Irvine JF Jr (1942) Radioactive tracer studies on arsenic injected as potassium arsenite. J Pharmacol Exp Ther 76:207–220Google Scholar
  45. International Agency for Research on Cancer (1987) Arsenic and arsenic compounds. In: IARC monograph on the evaluation of carcinogenic risks to humans — overall evaluations of carcinogenicity: an update of IARC Monographs 1 to 42, [Suppl 7], Lyon, p 100Google Scholar
  46. Ji G, Silver S (1992) Reduction of arsenate to arsenite by the ArsC protein of the arsenic resistance operon of Staphylococcus aureus plasmid pI258. Proc Natl Acad Sci USA 89:9474–9478PubMedGoogle Scholar
  47. Joint WHO/FAO Expert Committee on Food Additives (1989) Evaluation of certain food additives and contaminants, 33rd report, technical report series 776. WHO, Geneva, p 27Google Scholar
  48. Kurosawa S, Yasuda K, Taguchi M, Yamazaki S, Toda S, Morite M, Uehiro T, Fuga K (1980) Identification of arsenobetaine, a water soluble arsenic compound in muscle and liver of a shark Prionace glauca. Agric Biol Chem 44:1993–1994Google Scholar
  49. Lakso JU, Peoples SA (1975) Methylation of inorganic arsenic by mammals. J Agric Food Chem 23:674–676PubMedGoogle Scholar
  50. Lanz H, Wallace PC, Hamilton JG (1950) The metabolism of arsenic in laboratory animals using As74 as a tracer. Univ Calif Publ Pharmacol 2:253–282Google Scholar
  51. Lee T-C, Wei ML, Chang WJ, Ho IC, Lo JF, Jan KY, Huang H (1989) Elevation of glutathione and glutathione S-transferase activity in arsenic resistant Chinese hamster ovary cells. In Vitro Cell Dev Biol 25:442–448Google Scholar
  52. Lerman S, Clarkson TW (1983) The metabolism of arsenite and arsenate by the rat. Fund Appl Toxicol 3:309–314Google Scholar
  53. Luten JB, Riekwel-Booy G, Rauchbaar A (1982) Occurrence of arsenic in plaice (Pleuronectes platessa), nature of organo-arsenic compound present and its excretion by man. Environ Health Perspect 45:165–170PubMedGoogle Scholar
  54. Luten JB, Riekwel-Booy G, Greef JVD, ten Oever de Brauw MC (1983) Identification of arsenobetaine in sole, lemon sole, flounder, dab, crab and shrimps by field desorption and fast bombardment mass spectrometry. Chemosphere 12:131–141Google Scholar
  55. Mahieu P, Buchet J-P, Roels HA, Lauwerys R (1981) The metabolism of arsenic in humans acutely intoxicated by As2O3. Its significance for the duration of BAL therapy. Clin Toxicol 18:1067–1075PubMedGoogle Scholar
  56. Mahieu P, Buchet J-P, Lauwerys R (1987) Evolution clinique et biologique d’une intoxication orale aigue par l’anhydride arsenieux et considerations sur l’attitude therapeutique. J Toxicol Clin Exp 7:273–278PubMedGoogle Scholar
  57. Maiorino RM, Aposhian HV (1985) Dimercaptan metal-binding agents influence the biotransformation of arsenite in the rabbit. Toxicol Appl Pharmacol 77:240–250PubMedGoogle Scholar
  58. Marafante E, Vahter M (1984) The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem Biol Interact 50:49–57PubMedGoogle Scholar
  59. Marafante E, Vahter M (1986) The effect of dietary and chemically induced methylation deficiency on the metabolism of arsenate in the rabbit. Acta Pharmacol Toxicol 59 [Suppl 7]:35–38Google Scholar
  60. Marafante E, Vahter M, Dencker L (1984) Metabolism of arsenocholine in mice, rats and rabbits. Sci Total Environ 34:223–240PubMedGoogle Scholar
  61. Marafante E, Vahter M, Envall J (1985) The role of methylation in the detoxification of arsenate in the rabbit. Chem Biol Interact 56:225–238PubMedGoogle Scholar
  62. Marafante E, Vahter M, Norin H, Envall J, Sandström M, Christakopoulos A, Ryhage R (1987) Biotransformation of dimethylarsinic acid in mouse, hamster and man. J Appl Toxicol 7:111–117PubMedGoogle Scholar
  63. Mass MJ (1992) Human carcinogenesis by arsenic. Environ Geochem Health 14:49–54Google Scholar
  64. McBride BC, Wolfe RS (1971) Biosynthesis of dimethylarsine by methanobacterium. Biochemistry 10:4312–4317PubMedGoogle Scholar
  65. McKinney JD (1992) Metabolism and disposition of inorganic arsenic in laboratory animals and humans. Environ Geochem Health 14:43–48Google Scholar
  66. Mercer JF, Livingston J, Hall B, Paynter JA, Begy C, Chandrasekharappa S, Lockhart P, Grimes A, Bhave M, Siemieniak D et al. (1993) Isolation of a candidate gene for Menkes’ disease by positional cloning. Nature Genet 3:20–25PubMedGoogle Scholar
  67. Mergeay M (1991) Towards an understanding of the genetics of bacterial metal resistance. Trends Biotech 9:17–24Google Scholar
  68. Michalowsky LA, Jones PA (1989) DNA methylation and differentiation. Environ Health Perspect 80:189–197PubMedGoogle Scholar
  69. Mohri T, Hisanaga A, Ishinishi N (1990) Arsenic intake and excretion by Japanese adults: a 7-day duplicate diet study. Food Chem Toxicol 28:521–529PubMedGoogle Scholar
  70. Moody JP, Williams RT (1964a) The fate of 4-nitrophenylarsonic acid in hens. Food Cosmet Toxicol 2:695–706Google Scholar
  71. Moody JP, Williams RT (1964b) The metabolism of 4-hydroxy-3-nitrophenylarsonic acid in hens. Food Cosmet Toxicol 2:707–715Google Scholar
  72. Murai T, Iwata H, Otoshi T, Endo G, Horiguchi S, Fukushima S (1993) Renal lesions induced in F344/DuCrj rats by 4 weeks oral administration of dimethylarsenic acid. Toxicol Lett 66:53–61PubMedGoogle Scholar
  73. National Research Council (1977) Medical and biologic effects of environmental pollutants. Arsenic. National Academy of Sciences, Washington DC, p 16Google Scholar
  74. Newberne PM, Rogers AE (1986) Labile methyl groups and the promotion of cancer. Annu Rev Nutr 6:407–432PubMedGoogle Scholar
  75. Norin H, Christakopoulos A (1982) Evidence for the presence of arsenobetaine and other organoarsenicals in shrimps. Chemosphere 11:287–298Google Scholar
  76. Norin H, Ryhage R, Christakopoulos A, Sandström (1983) New evidence for the presence of arsenobetaine in shrimps (Pandalus borealis) by use of pyrolysis gas chromatography-atomic absorption spectrometry /mass spectromety. Chemosphere 12:299–315Google Scholar
  77. Norin H, Vahter M, Christakopoulos, Sandstrom M (1985) Concentration of inorganic and total arsenic in fish from industrially polluted water. Chemosphere 14:325–334Google Scholar
  78. Odanaka Y, Matano O, Goto S (1980) Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull Environ Contam Toxicol 24:452–459Google Scholar
  79. Offergelt JA, Roels H, Buchet JP, Boeckx M, Lauwerys R (1992) Relation between airborne arsenic trioxide and urinary excretion of inorganic arsenic and its methylated metabolites. Br J Ind Med 49:387–393PubMedGoogle Scholar
  80. Overby LR, Frederickson RL (1963) Metabolic stability of radioactive arsanilic acid in chickens. J Agric Food Chem 11:378–381Google Scholar
  81. Overby LR, Frederickson RL (1965) Metabolism of arsanilic acid. II. Localization and type of arsenic excreted and retained by chickens. Toxicol Appl Pharmacol 7:855–867PubMedGoogle Scholar
  82. Overby LR, Straube L (1965) Metabolism of arsanilic acid. I. Metabolic stability of double labeled arsanilic acid in chickens. Toxicol Appl Pharmacol 7:850–854PubMedGoogle Scholar
  83. Peoples SA (1964) Review of arsenical pesticides. In:Woolson EA (ed) Arsenical pesticides. ACS, Washington DC, p 1 (ACS symposium series 7)Google Scholar
  84. Peoples SA (1969) The failure of methanearsonic acid to cross the blood-mammary barrier when administered orally to lactating cows. Fed Proc 28:359 (abstract)Google Scholar
  85. Pershagen G, Bjorklund N-E (1985) On the pulmonary tumorigenicity of arsenic trioxide and calcium arsenate in hamsters. Cancer Lett 27:99–104PubMedGoogle Scholar
  86. Pershagen G, Nordberg G, Bjorklund N-E (1984) Carcinomas of the respiratory tract in hamsters given arsenic trioxide and/or benzo(a)pyrene by the pulmonary route. Environ Res 34:227–241PubMedGoogle Scholar
  87. Petito CT, Beck BD (1991) Evaluation of evidence of nonlinearities in the dose-response curve for arsenic carcinogenesis. Trace Subst Environ Health 24:143–176Google Scholar
  88. Pomroy C, Charbonneau SM, McCullough RS, Tam GKH (1980) Human retention studies with 74As. Toxicol Appl Pharmacol 53:550–556PubMedGoogle Scholar
  89. Rogers EH, Chernoff N, Kavlock RJ (1981) The teratogenic potential of cacodylic acid in the rat and mouse. Drug Chem Toxicol 4:49–61PubMedGoogle Scholar
  90. Rosen BP, Weigel U, Monticello R, Edwards BPF (1991) Molecular analysis of an anion pump. Arch Biochem Biophys 284:381–385PubMedGoogle Scholar
  91. Rowland IR, Davies MJ (1981) In vitro metabolism of inorganic arsenic by the gastro-intestinal microflora of the rat. J Appl Toxicol 1:278–283PubMedGoogle Scholar
  92. Rudnai P, Borzsonyi M (1980) Carcinogenic effect of arsenic trioxide in transplacentally and neonatally treated CFLP mice. Nat Sci 2:11–18Google Scholar
  93. Scott N, Hatlelid KM, MacKenzie NE, Carter DE (1993) Reaction of arsenic(III) and arsenic(V) species with glutathione. Chem Res Toxicol 6:102–106PubMedGoogle Scholar
  94. Shibata Y, Yoshinaga J, Morita M (1993) Detection of arsenobetaine in human blood. In: Book of abstracts, 6th international symposium on environmental and industrial arsenic, Kawasaki, Japan, p 12Google Scholar
  95. Silver S, Ji G, Broer S, Dey S, Dou D, Rosen BP (1993a) Orphan enzyme or patriarch of a new tribe:the arsenic resistance ATPase of bacterial plasmids. Mol Microbiol 8:637–642Google Scholar
  96. Silver S, Nucifora G, Phung LT (1993b) Human Menkes X-chromosome disease and the staphylococcal cadmium-resistance ATPase:a remarkable similarity in protein sequence. Mol Microbiol 10:7–12Google Scholar
  97. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ, Smyth MT (1992) Cancer risks from arsenic in drinking water. Environ Health Perspect 97:259–267PubMedGoogle Scholar
  98. Stevens JT, DiPasquale LC, Farmer JD (1979) The acute inhalation toxicology of the technical grade organoarsenical herbicides, cacodylic acid and disodium methanearsonic acid: a route comparison. Bull Environ Contam Toxicol 21:304–311PubMedGoogle Scholar
  99. Takahashi K, Yamauchi H, Yamato N, Yamamura Y (1988) Methylation of arsenic trioxide in hamsters with liver damage induced by long-term administration of carbon tetrachloride. Appl Organomet Chem 2:309–314Google Scholar
  100. Takahashi K, Yamauchi H, Mashiko M, Yamamura Y (1990) Effect of S-adenosyl methionine on methylation of inorganic arsenic. Nippon Eiseigaku Zasshi 45:613–618PubMedGoogle Scholar
  101. Tam GKH, Charbonneau SM, Bryce F, Lacroix G (1978) Separation of arsenic metabolites in dog plasma and urine following intravenous injection of 74As. Anal Biochem 86:505–511PubMedGoogle Scholar
  102. Tam GKH, Charbonneau SM, Bryce F, Pomroy C, Sandi E (1979) Metabolism of inorganic arsenic (74As) in humans following oral ingestion. Toxicol Appl Pharmacol 50:319–322PubMedGoogle Scholar
  103. Tam GKH, Charbonneau SM, Bryce F, Sandi E (1982) Excretion of a single oral dose of fish-arsenic in man. Bull Environ Contam Toxicol 28:669–673PubMedGoogle Scholar
  104. Tezuka M, Hanioka K-I, Yamanaka K, Okada S (1993) Gene damage induced in human alveolar type II (L-132) cells by exposure to dimethylarsinic acid. Biochem Biophys Res Commun 1991:1178–1183Google Scholar
  105. Thomas DJ (1994) Arsenic toxicity in humans:research problems and prospects. Environ Geochem Health (in press)Google Scholar
  106. Thompson DJ (1993) A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact 88:89–114PubMedGoogle Scholar
  107. Tseng W-P (1989) Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 40:547–558PubMedGoogle Scholar
  108. Tseng W-P, Chu HM, How SW, Fong JM, Lin CS, Yeh S (1968) Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst 40:453–463PubMedGoogle Scholar
  109. US Environmental Protection Agency (1988) Special report on ingested inorganic arsenic-skin cancer; nutritional essentiality. Risk Assessment Forum, EPA/625/3-87/013, Washington DCGoogle Scholar
  110. Vahter M (1981) Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. Environ Res 25:286–293PubMedGoogle Scholar
  111. Vahter M (1986) Environmental and occupational exposure to inorganic arsenic. Acta Pharmacol Toxicol 59 [Suppl 7]:31–34Google Scholar
  112. Vahter M, Envall J (1983) In vivo reduction of arsenate in mice and rabbits. Environ Res 32:14–24PubMedGoogle Scholar
  113. Vahter M, Marafante E (1985) Reduction and binding of arsenate in marmoset monkeys. Arch Toxicol 57:119–124PubMedGoogle Scholar
  114. Vahter M, Marafante E (1987) Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 37:41–46PubMedGoogle Scholar
  115. Vahter M, Marafante E, Lindgren A, Dencker L (1982) Tissue distribution and subcellular binding of arsenic in marmoset monkeys after injection of 74As arsenite. Arch Toxicol 51:65–77Google Scholar
  116. Vahter M, Marafante E, Dencker L (1983) Metabolism of arsenobetaine in mice, rats and rabbits. Sci Total Environ 30:197–211PubMedGoogle Scholar
  117. Vulpe C, Levinson B, Whitney S, Packman S, Gitscher J (1993) Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nature Genet 3:7–13PubMedGoogle Scholar
  118. Wang H-F, Lee T-C (1993) Glutathione S-transferase pi facilitates the excretion of arsenic from arsenic resistant Chinese hamster ovary cells. Biochem Biophys Res Commun 192:1093–1099PubMedGoogle Scholar
  119. Weinshilboum R (1988) Pharmacogenetics of methylation:Relationship to drug metabolism. Clin Biochem 21:201–210PubMedGoogle Scholar
  120. Wu J, Rosen BP (1993) Metalloregulated expression of the ars operon. J Biol Chem 268:52–58PubMedGoogle Scholar
  121. Wu MM, Kuo TL, Hwang YH, Chen CJ (1989) Dose-response relation between arsenic concentration in well water and mortality from cancer and cardiovascular disease. Am J Epidemiol 130:1123–1132PubMedGoogle Scholar
  122. Yamamura Y (1993) Toxicity and metabolism of alkylarsine. In:Book of abstracts, 6th international symposium on environmental and industrial arsenic. Kawasaki, Japan, p 4Google Scholar
  123. Yamamura Y, Yamauchi H (1980) Arsenic metabolites in hair, blood and urine in workers exposed to arsenic trioxide. Ind Health 18:203–210PubMedGoogle Scholar
  124. Yamanaka K, Hasegawa A, Sawamura R, Okada S (1989) Dimethylated arsenics induce DNA strand breaks in lung via the production of acitve oxygen in mice. Biochem Biophys Res Commun 165:43–50PubMedGoogle Scholar
  125. Yamanaka K, Hoshino H, Sawamura R, Hasegawa A, Okada S (1990) Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem Biophys Res Commun 168:58–64PubMedGoogle Scholar
  126. Yamanaka K, Hasegawa A, Sawamura R, Okada S (1991) Cellular responses to oxidative damage in lung induced by the administration of dimethylarsinic acid, a metabolite of inorganic arsenics, in mice. Toxicol Appl Pharmacol 108:205–215PubMedGoogle Scholar
  127. Yamanaka K, Tezuka M, Kato K, Hasegawa A, Okada S (1993) Crosslink formation between DNA and nuclear proteins by in vivo exposure of cells to dimethylar-sinic acid. Biochem Biophys Res Commun 191:1184–1191PubMedGoogle Scholar
  128. Yamauchi H, Yamamura Y (1979) Urinary inorganic arsenic and methylarsenic excretion following arsenate-rich seaweed ingestion. Jpn J Ind Health 21:47–54Google Scholar
  129. Yamauchi H, Yamamura Y (1984a) Metabolism and excretion of orally administered dimethylarsinic acid in the hamster. Toxicol Appl Pharmacol 74:134–140Google Scholar
  130. Yamauchi H, Yamamura Y (1984b) Metabolism and excretion of orally ingested trimethylarsenic in man. Bull Environ Contam Toxicol 32:682–687Google Scholar
  131. Yamauchi H, Yamamura Y (1985) Metabolism and excretion of orally administered arsenic trioxide in the hamster. Toxicology 34:113–121PubMedGoogle Scholar
  132. Yamauchi H, Yamamura Y (1986) Metabolism and excretion of orally and intra-peritoneally administered gallium arsenide in the hamsters. Toxicology 40:237–246PubMedGoogle Scholar
  133. Yamauchi H, Yamato N, Yamamura Y (1988) Metabolism and excretion of orally and intraperitoneally administered methylarsonic acid in the hamster. Bull Environ Contam Toxicol 40:280–286PubMedGoogle Scholar
  134. Yamauchi H, Takahashi K, Mashiko M, Yamamura Y (1989) Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair. Am Ind Hyg Assoc J 50:606–612PubMedGoogle Scholar
  135. Yamauchi H, Kaise T, Takahashi K, Yamamura Y (1990) Toxicity and metabolism of trimethylarsine in mice and hamster. Fund Appl Toxicol 14:399–407Google Scholar
  136. Yamauchi H, Takahashi K, Mashiko M, Saitoh J, Yamamura Y (1992) Intake of different chemical species of dietary arsenic by the Japanese and their blood and urinary arsenic levels. Appl Organomet Chem 6:383–388Google Scholar
  137. Zeisel SH (1988) “Vitamin-like” molecules (A) choline. In: Shils ME, Young VR (eds) Modern nutrition in health and disease, 7th den. Lea and Febiger, Philadelphia, p 440Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1995

Authors and Affiliations

  • M. Styblo
  • M. Delnomdedieu
  • D. J. Thomas

There are no affiliations available

Personalised recommendations